Save as Favorite
Sign in to receive recommendations (Learn more)

Afinitor (chemical name: everolimus) is approved by the U.S. Food and Drug Administration to be used in combination with Aromasin (chemical name: exemestane) to treat advanced-stage, hormone-receptor-positive, HER2-negative breast cancer in postmenopausal women that has already been treated with Femara (chemical name: letrozole) or Arimidex (chemical name: anastrozole).

In this section you can learn more about:

Join the Conversation

Was this article helpful? Yes / No

Leer esta página en español

Eoy18 sidebar 1
Back to Top